Preclinical evaluation of an 18F-labelled β1-adrenoceptor selective radioligand based on ICI 89,406

Nuclear Medicine and Biology

Volumn 37, Issue 4, 2010, Pages 517-526

  Law, Marilyn P ^a,c   Wagner, Stefan ^a   Kopka, Klaus ^a   Renner, Christiane ^a   Pike, Victor W ^b   Schober, Otmar ^a   Schäfers, Michael ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

1 adrenoceptor selective radioligand; 18F Fluoroethoxy ICI 89,406 for PET; Myocardial 1 adrenoceptors; PET radioligand; Small animal PET

Indexed keywords

1 (2 CYANOPHENOXY) 3 [2 (3 PHENYLUREIDO)ETHYLAMINO] 2 PROPANOL; 1 (2 CYANOPHENOXY) 3 [2 (3 PHENYLUREIDO)ETHYLAMINO] 2 PROPANOL F 18; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 1 ADRENERGIC RECEPTOR; PROPRANOLOL; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; LIGAND; PROPANOLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION; URINALYSIS; ANIMAL; CHEMISTRY; ENZYME SPECIFICITY; METABOLISM; RADIOCHEMISTRY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORINE RADIOISOTOPES; LIGANDS; MALE; MICE; POSITRON-EMISSION TOMOGRAPHY; PROPANOLAMINES; RADIOCHEMISTRY; RATS; RECEPTORS, ADRENERGIC, BETA-1; SUBSTRATE SPECIFICITY;

EID: 77952634960     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.01.004     Document Type: Article

References (42)

1. Molenaar P., Parsonage W.A. Fundamental considerations of β-adrenoceptor subtypes in human heart failure. Trends Pharmacol Sci 2005, 26:368-375.
2. Brodde O.-E., Bruck H., Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 2006, 100:323-337.
3. Lohse M.J., Engelhardt S., Eschenhagen T. What is the role of β-adrenergic signaling in heart failure?. Circ Res 2003, 93:896-906.
4. 2-adrenoceptor stimulation in heart failure. J Cardiovasc Pharmacol 1990, 16(Suppl 5):S133-S137.
5. 2 adrenoceptors in different human heart diseases. Naunyn-Schmiedeberg's Arch Pharmacol 1991, 343:217-220.
6. 2-adrenoceptors in the failing and nonfailing human heart. Eur J Clin Pharmacol 1992, 42:607-611.
7. 2 subtypes. J Cardiothorac Vasc Anesth 1993, 7:668-673.
8. 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 1989, 14:323-331.
9. Leineweber K., Büscher R., Bruck H., Brodde D.-E. β-adrenoceptor polymorphisms. Naunyn-Schmiedeberg's Arch Pharmacol 2004, 369:1-22.
10. Schäfers M., Dutka D., Rhodes C.G., Lammertsma A.A., Hermansen F., Schober O., et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 1998, 82:57-62.
11. Schäfers M., Lerch H., Wichter T., Rhodes C.G., Lammertsma A.A., Borggrefe M., et al. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 1998, 32:181-186.
12. Wichter T., Schäfers M., Rhodes C.G., Borggrefe M., Lerch H., Lammertsma A.A., et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic β-adrenergic receptor density with positron emission tomography. Circulation 2000, 101:1552-1558.
13. Kies P., Wichter T., Schäfers M., Paul M., Schäfers K.P., Eckardt L., et al. Abnormal myocardial presynaptic norepinephrine recycling in patients with the Brugada syndrome. Circulation 2004, 110:3017-3022.
14. 11C]CGP12388. Eur J Nucl Med Mol Imaging 2005, 32:443-447.
15. 11C-CGP 12388. Chest 2005, 128:3020-3027.
16. Kopka K., Law M.P., Breyholz H.J., Faust A., Höltke C., Riemann B., Schober O., et al. Non-invasive molecular imaging of β-adrenoceptors in vivo: perspectives for PET-radioligands. Curr Med Chem 2005, 12:2057-2074.
17. Imperial Chemical Industries Limited, London (UK), Patent CH 605666 1978; DE 2458908 1975. Chem Abstr, 84:43599.
18. Majid P.A., Schreuder J.E., de Feyter P.J., Roos J.P. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective β-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris. J Cardiovasc Pharmacol 1980, 2:435-444.
19. Svendsen T.L., Hartling O., Trap-Jensen J. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. Eur J Clin Pharmacol 1979, 15:223-228.
20. 1-selective adrenoceptor ligands as potential radioligands for in vivo imaging. Bioorg Med Chem 2003, 11:3513-3527.
21. 125I]-ICI-H. Nuklearmedizin 2003, 42:173-180.
22. Wagner S., Kopka K., Law M.P., Riemann B., Pike V.W., Schober O., et al. Synthesis and first in vivo evaluation of new selective high affinity -adrenoceptor radioligands for SPECT based on ICI 89,406. Bioorg Med Chem 2004, 12:4117-4132.
23. 1-adrenoceptor selective radioligands suitable for PET?. Eur J Nucl Med Mol Imaging 2008, 35:174-185.
24. 1-adrenoceptor PET radioligand based on ICI 89,406. J Label Compd Radiopharm 2006, 49:177-195.
25. 1-adrenoceptor PET radioligands. J Label Compd Radiopharm 2005, 48:721-733.
26. Law M.P. Demonstration of the suitability of CGP 12177 for in vivo studies of β-adrenoceptors. Brit J Pharmacol 1993, 109:1101-1109.
27. Jeavons A.P., Chandler R.A., Deuttman C.A.R. A 3D HIDAC-PET camera with sub-millimeter resolution for imaging small animals. IEEE Trans Nucl Sci 1999, 3:468-473.
28. Schäfers K.P., Reader A.J., Kriens M., Knoess C., Schober O., Schäfers M. Performance Evaluation of the 32-module quadHIDAC small animal PET scanner. J Nucl Med 2005, 46:996-1004.
29. Reader A.J., Ally S., Bakatselos F., Manavaki R., Walledge R.J., Jeavons A.P., et al. One-pass list-mode EM algorithm for high resolution 3D PET image reconstruction into large arrays. IEEE Trans Nucl Sci 2002, 49:693-699.
30. 18F]fluorocarazolol for in vivo imaging and quantification of cerebral beta-adrenoceptors. Eur J Pharmacol 1998, 353:215-226.
31. 1-adrenoceptors with positron emission tomography. Eur J Nucl Med 2000, 27:7-17.
32. Hume S.P., Gunn R.N., Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med 1988, 25:173-176.
33. Minneman K.P., Hegstrand L.R., Molinoff P.B. Simultaneous determination of beta-1 and beta-2-adrenergic Receptors in tissues containing both receptor subtypes. Mol Pharmacol 1979, 16:34-46.
34. 3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn-Schmiedeberg's Arch Pharmacol 1987, 336:519-525.
35. 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling. Naunyn-Schmiedeberg's Arch Pharmacol 2003, 368:366-376.
36. Myslivecek J., Nováková M., Palkovits M., Križanoyá O., Kvetnanskỳ R. Distribution of mRNA and binding sites of adrenoceptors and muscarinic receptors in the rat heart. Life Sci 2006, 79:112-120.
37. Horinouchi T., Morishima S., Tanaka T., Suzuki F., Tanaka Y., Koike K., et al. Pharmacological evaluation of plasma membrane β-adrenoceptors in rat hearts using the tissue segment binding method. Life Sc 2006, 79:941-948.
38. 2-adrenoceptor agonist, in canine trachea and rat heart. Pharmacology 1996, 53:19-27.
39. Klunder J.M., Onami T., Sharpless K.B. Arenesulfonate derivatives of homochiral building blocks for organic synthesis. J Org Chem 1989, 54:1295-1304.
40. Van Dort M.E., Jung Y.W.J., Sherman P.S., Kilbourn M.R., Wieland D.M. Fluorine for hydroxysubstitution in biogenic amines: asymmetric synthesis and biological evaluation of fluorine-18-labelled β-fluorophenylalkylamines as model systems. J Med Chem 1995, 38:810-815.
41. Renner C., Höltke C., Wagner S., Faust A., Schober O., Kopka K., et al. Substitution der Hydroxylgruppe in einer Betablockerstruktur durch radioaktives Fluor. Nuklearmedizin 2009, 48:A38.
42. 1-adrenoceptor binding affinity of a series of phenoxypropanolamines. Eur J Med Chem 2002, 37:111-125.